Sunshine Heart Inc (CHFS) Upgraded at ValuEngine

ValuEngine upgraded shares of Sunshine Heart Inc (NASDAQ:CHFS) from a strong sell rating to a sell rating in a report released on Tuesday.

Sunshine Heart (NASDAQ:CHFS) opened at $6.53 on Tuesday.

ILLEGAL ACTIVITY WARNING: “Sunshine Heart Inc (CHFS) Upgraded at ValuEngine” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at

In related news, major shareholder Ki Yong Choi purchased 61,645 shares of the company’s stock in a transaction on Thursday, October 12th. The stock was bought at an average price of $0.52 per share, with a total value of $32,055.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.00% of the company’s stock.

About Sunshine Heart

CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

To view ValuEngine’s full report, visit ValuEngine’s official website.

What are top analysts saying about Sunshine Heart Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sunshine Heart Inc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit